Neurim is engaged in the development of drug therapies for the treatment of age-related disorders... Read more
Neurim Pharmaceuticals Co-Founder & CEO: Nava Zisapel

Co-Founder & CEO

Nava Zisapel

CEO Approval Rating

90/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?

News

Jul 31, 2024
Pharmabiz
Neurim Pharmaceuticals: EMA committee recommends approval of Neurim Pharma's Slenyto to treat insomnia in children with NGDs
Aug 28, 2018
BioPortfolio
Neurim Pharmaceuticals: Neurim Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 11072018 Prices from USD $250
Jul 30, 2018
PharmiWeb
Neurim Pharmaceuticals: Neurim Pharmaceuticals Receives Positive CHMP Opinion for Slenyto (Pediatric Prolonged-Release Melatonin) for the Treatment of Insomnia in Children With Autism Spectrum Disorder (ASD)
Apr 29, 2018
BioPortfolio
Neurim Pharmaceuticals: Neurim Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Jan 17, 2018
PR Newswire
Press Release: Neurim Pharmaceuticals : Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ("PedPRM") to Be Marketed by BIOCODEX Oy in Finland
Oct 10, 2017
BioSpace
Neurim Pharmaceuticals: Positive Phase III Results For Neurim Pharmaceuticals' Pediatric Prolonged-Release Melatonin For Insomnia In Children With Autism Spectrum Disorder (ASD) Presented At In Prague
Sep 25, 2017
PR Newswire
Press Release: Neurim Pharmaceuticals : Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ('PedPRM') to be Marketed by Flynn Pharma in UK and Ireland
Aug 30, 2017
BioPortfolio
Neurim Pharmaceuticals: Neurim Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24082017 Prices from USD $250
Mar 28, 2017
BioSpace
Neurim Pharmaceuticals: Neurim Pharmaceuticals Grants Marketing Rights for Paediatric Prolonged-Release Melatonin ("PedPRM") In Spain
Mar 12, 2017
BioSpace
Neurim Pharmaceuticals: Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin ('PedPRM') To Be Marketed By Biocodex In France

Neurim Pharmaceuticals Competitors

1Anavex
2Pfizer
3AbbVie
4Novartis
5GSK
6Biogen
7Merck
8Lilly
9Johnson & Johnson
10Roche

Trending Companies